Valaris remains a Strong Buy, supported by robust fleet quality, stable OPEX, and favorable medium-term rate dynamics. The Transocean all-stock merger offers a 4.8% arbitrage upside, with regulatory approvals progressing and minimal integration costs expected. Recent revenue and EPS misses are attributed to temporary fleet idle days, not structural weakness; VAL backlog growth signals utilization rebound to ~80% in H2.









